Orchestra BioMed Holdings (OBIO) Total Debt (2021 - 2026)

Orchestra BioMed Holdings (OBIO) has reported Total Debt for 5 consecutive years, with $14.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Debt changed 0.03% year-over-year to $14.3 million; the TTM figure through Mar 2026 stood at $14.3 million (changed 0.03% YoY), while the FY2025 annual figure was $14.3 million, changed 0.17% from the prior year.
• Total Debt held at $14.3 million in Q1 2026 per OBIO's latest filing, from $14.3 million in the prior quarter.
• Across five years, Total Debt topped out at $14.4 million in Q2 2025 and bottomed at $9.5 million in Q4 2022.
• Historically, Total Debt has averaged $12.4 million across 5 years, with a median of $14.2 million in 2025.
• Annual changes were most pronounced in 2025 — Total Debt slipped 0.17% — and 2026, when it slipped 0.03%.
• Orchestra BioMed Holdings' Total Debt stood at $9.5 million in 2022, then advanced by 1.15% to $9.6 million in 2023, then soared by 48.89% to $14.3 million in 2024, then dropped by 0.17% to $14.3 million in 2025, then increased by 0.46% to $14.3 million in 2026.
• Business Quant data shows OBIO's Total Debt at $14.3 million in Q1 2026, $14.3 million in Q4 2025, and $14.2 million in Q3 2025.